Oracle Corporation (ORCL) traded within a range of $39.1 to $39.38 after opening the day at $39.12. The company has seen its stock increase in value by 2.38% so far this year. The stock was up close to 0.05% on light volume in last trading session and closed at $39.21 per share. After the recent gain, the stock is currently holding -5.71% below its 52 week high of $42 and 20.16% above its 12-month low of $33.59. The shares are up by over 2.46% in the last three months, and the RSI indicator value of 50.91 is neither bullish nor bearish, tempting investors to stay on the sidelines.
Oracle Corporation develops, manufactures, markets, sells, hosts, and supports database and middleware software, application software, cloud infrastructure, hardware systems, and related services worldwide. It offers services in three primary layers of the cloud: Software as a Service, Platform as a Service, and Infrastructure as a Service. The company licenses its Oracle Database software, which enables storage, retrieval, and manipulation of various forms of data; and Oracle Fusion Middleware software to build, deploy, secure, access, and integrate business applications, as well as automate their business processes. It also provides a range of software for mobile computing to address the development needs of businesses; and Java, a software development language. In addition, the company offers application software, such as human capital and talent management, customer experience and customer relationship management, financial management and governance, risk and compliance, procurement, project portfolio management, supply chain management, business analytics and enterprise performance management, and industry-specific application software. Further, it offers hardware systems products, such as Oracle Engineered Systems, servers, storage, networking, industry specific hardware, virtualization software, operating systems, management software, and related hardware services. Additionally, the company offers customers with rights to software product upgrades and maintenance releases, patches released, and Internet access to technical content, as well as Internet and telephone access to technical support personnel. The company also provides consulting services, such as IT strategy alignment, enterprise architecture planning and design, initial product implementation and integration, and ongoing product enhancement and upgrade; customer support services; and education services. Oracle Corporation was founded in 1977 and is headquartered in Redwood City, California.
Facebook, Inc. (FB) failed to extend gains with the stock declining -0.29% or $-0.37 to close the day at $127.55 on light trading volume of 12.16M shares, compared to its three month average trading volume of 22.84M. The Menlo Park California 94025 based company has been outperforming the internet information providers group over the past 52 weeks, with the stock gaining 35.19%, compared to the industry which has advanced 19.11% over the same period. With RSI of 69.31, the stock should still continue to rise and get closer to its one year target estimate of $153.57, making it a hold for now.
Facebook, Inc. operates as a mobile application and Website that enables people to connect, share, discover, and communicate each other on mobile devices and personal computers worldwide. Its solutions also include Instagram, a mobile application that enables people to take photos or videos, customize them with filter effects, and share them with friends and followers in a photo feed or send them directly to friends; Messenger, a messaging application for mobile and Web on various platforms and devices, which enable people to reach others instantly, as well as enable businesses to engage with customers; and WhatsApp Messenger, a mobile messaging application. The company also develops Oculus virtual reality technology and content platform, which allow people to enter an immersive and interactive environment to play games, consume content, and connect with others. As of December 31, 2015, it had 1.04 billion daily active users (DAUs) and 934 million DAUs who accessed Facebook from a mobile device. The company has a partnership with the Federation of Indian Chambers of Commerce and Industry to augment the Millennium Alliance initiative, as well as support and expand the development of the social enterprise sector in India. Facebook, Inc. was founded in 2004 and is headquartered in Menlo Park, California.
Merck & Co., Inc. (MRK) dropped $-0.84 to close the day at a new closing price of $60.33, a -1.37% decrease in value from its previous closing price that moved the stock 29.83% above its 52 week low of $47.97. A total of 11.28M shares exchanged hands during the day compared with its three month average trading volume of 11.11M. The stock, which fluctuated between $60.07 and $61.08 during the day, currently situated -7.13% below its 52 week high. The stock is down by -3.38% in the past one month and down by -2.09% over the past three months. With a one year target estimate of $0 and RSI of 46.04, the stock still has upside potential, making it a hold for now.
Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases. It also offers neuromuscular blocking agents; anti-bacterial products; cholesterol modifying medicines; non-sedating antihistamine; and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat brain tumors; treat melanoma and metastatic non-small-cell lung cancer; prevent diseases caused by human papillomavirus; and vaccines for measles, mumps, rubella, varicella, chickenpox, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics and vaccines for fishes. Additionally, the company offers companion animal products, such as ointments for otitis; diabetes mellitus treatment for dogs and cats; anthelmintic products; chewable tablets to treat fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. It serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures to develop molecule compounds for various cancer treatments. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.